Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

New 'patch' drug therapy for Alzheimer's has fewer side effects

Alzheimer's, is the most common form of dementia and affects as many as 15 million people worldwide.

20 Jul 2006

Drugs given to stop nausea and vomiting after surgery help only a few people

Between 10 - 28% of people benefit from taking an anti-emetic drug to prevent nausea or vomiting after surgery - this means that if everyone was given the drug the majority of patients would be exposed to the risk of side-effects without gaining any benefit.

19 Jul 2006

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

A class of drugs commonly used to treat typical influenza symptoms such as fever, headache and cough do not prevent people from becoming infected with the flu virus.

19 Jul 2006

Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.

19 Jul 2006

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adult

A new analysis of existing research offers confirmation that taking a break from AIDS drugs is a bad idea for HIV patients with uncontrolled cases of the disease.

19 Jul 2006

Drugs for preventing postoperative nausea and vomiting

Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are frequently given drugs to prevent this. But the majority of patients won't benefit from these drugs, according to a large new review of studies.

19 Jul 2006

The facts on dieting

Only 'circumstantial' evidence supporting poor diet and lack of exercise as the main causes of obesity.

17 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Morning sickness - a form of protection for mother and baby

As many as 90% of mothers experience nausea during pregnancy, and about half that number vomit.

12 Jul 2006

Two-thirds of patients say Uprima didn't work for them

Two-thirds of patients stopped using Uprima, a drug commonly prescribed for erection problems, because they felt it wasn't effective, according to a large-scale study published in the July issue of the urology journal BJU International.

10 Jul 2006

Chantix may help smokers quit

Chantix (varenicline) was shown to be effective with a favorable safety profile as an aid to smoking cessation treatment, according to three pivotal studies published in this week's Journal of the American Medical Association.

5 Jul 2006

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence.

5 Jul 2006

Varenicline effective in helping smokers quit

The drug varenicline shows effectiveness in helping smokers quit and abstain from smoking when compared to placebo and the smoking cessation medication bupropion.

4 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

FDA approves Exelon to treat dementia of Parkinson's disease

FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.

27 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Zap that migraine before it even starts!

Millions of people who suffer from migraine could be helped by an experimental device which zaps the pain before an attack gets going.

22 Jun 2006

FDA warns of possible risks to children using Triaminic Vapor Patch

The U.S. Food and Drug Administration (FDA) today is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children.

19 Jun 2006